Julien Perrin

693 total citations
33 papers, 239 citations indexed

About

Julien Perrin is a scholar working on Physiology, Hematology and Genetics. According to data from OpenAlex, Julien Perrin has authored 33 papers receiving a total of 239 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Physiology, 11 papers in Hematology and 10 papers in Genetics. Recurrent topics in Julien Perrin's work include Erythrocyte Function and Pathophysiology (10 papers), Hemoglobinopathies and Related Disorders (8 papers) and Blood properties and coagulation (5 papers). Julien Perrin is often cited by papers focused on Erythrocyte Function and Pathophysiology (10 papers), Hemoglobinopathies and Related Disorders (8 papers) and Blood properties and coagulation (5 papers). Julien Perrin collaborates with scholars based in France and Switzerland. Julien Perrin's co-authors include Jean‐François Lesesve, Claude Vigneron, Jean‐Christophe Lacour, Sébastien Richard, Xavier Ducrocq, Delphine Gérard, Thomas Lecompte, Andrê S. H. Prévôt, Pierre-Alexandre Baillot and Marianne Parent and has published in prestigious journals such as Blood, PLoS ONE and International Journal of Pharmaceutics.

In The Last Decade

Julien Perrin

31 papers receiving 234 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julien Perrin France 9 66 60 44 41 30 33 239
Aleksandr Shamanaev Russia 12 54 0.8× 115 1.9× 150 3.4× 30 0.7× 8 0.3× 29 332
Anna Kieronska‐Rudek Poland 9 93 1.4× 14 0.2× 8 0.2× 50 1.2× 19 0.6× 17 282
Amit Manhas United States 10 92 1.4× 11 0.2× 13 0.3× 18 0.4× 25 0.8× 33 261
Paolo Alberti Italy 10 64 1.0× 36 0.6× 12 0.3× 50 1.2× 18 0.6× 15 335
Henry Chan New Zealand 11 179 2.7× 78 1.3× 56 1.3× 140 3.4× 15 0.5× 37 414
Xin Tian China 10 69 1.0× 27 0.5× 30 0.7× 30 0.7× 2 0.1× 34 246
Y Fukumura Japan 12 99 1.5× 19 0.3× 11 0.3× 31 0.8× 3 0.1× 35 391
R. D. Abeysinghe United Kingdom 9 56 0.8× 145 2.4× 135 3.1× 19 0.5× 35 1.2× 10 316
Varinder Kaur United States 8 68 1.0× 70 1.2× 66 1.5× 15 0.4× 2 0.1× 41 270
Kittiphong Paiboonsukwong Thailand 11 180 2.7× 159 2.6× 203 4.6× 66 1.6× 2 0.1× 37 440

Countries citing papers authored by Julien Perrin

Since Specialization
Citations

This map shows the geographic impact of Julien Perrin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julien Perrin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julien Perrin more than expected).

Fields of papers citing papers by Julien Perrin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julien Perrin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julien Perrin. The network helps show where Julien Perrin may publish in the future.

Co-authorship network of co-authors of Julien Perrin

This figure shows the co-authorship network connecting the top 25 collaborators of Julien Perrin. A scholar is included among the top collaborators of Julien Perrin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julien Perrin. Julien Perrin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gérard, Delphine, et al.. (2024). Infantile pyknocytosis, a neonatal hemolytic anemia with Heinz bodies: A cohort study. Pediatric Blood & Cancer. 71(8). e31078–e31078. 2 indexed citations
2.
Wu, Meiling, et al.. (2024). Heparinized collagen-based hydrogels for tissue engineering: physical, mechanical and biological properties. International Journal of Pharmaceutics. 670. 125126–125126. 3 indexed citations
3.
Lagrange, Jérémy, Djésia Arnone, Huguette Louis, et al.. (2023). The Role of Platelets and von Willebrand Factor in the Procoagulant Phenotype of Inflammatory Bowel Disease. Journal of Crohn s and Colitis. 18(5). 751–761. 6 indexed citations
4.
Perrin, Julien, et al.. (2023). A Serious Game About Hematology for Health Care Workers (SUPER HEMO): Development and Validation Study. JMIR Serious Games. 11. e40350–e40350. 7 indexed citations
5.
Denis, Cécile V., Stéphanie Roullet, & Julien Perrin. (2022). Von Willebrand factor and cancer: Another piece of the puzzle. Journal of Thrombosis and Haemostasis. 20(10). 2207–2210. 1 indexed citations
6.
Gérard, Delphine, et al.. (2020). Previously misdiagnosed red cell membrane disorder and familial consequences. British Journal of Haematology. 190(6). 810–810. 3 indexed citations
7.
Gérard, Delphine, et al.. (2019). Hyperthyroidism: acquired cause of an increase in haemoglobin A2 level. Annales de biologie clinique. 77(4). 436–438. 1 indexed citations
8.
Parent, Marianne, Ariane Boudier, Julien Perrin, et al.. (2015). In Situ Microparticles Loaded with S-Nitrosoglutathione Protect from Stroke. PLoS ONE. 10(12). e0144659–e0144659. 23 indexed citations
9.
Perrin, Julien, Cyril Charron, Elisabeth M. Cramer, et al.. (2014). Coagulation Phenotypes in Septic Shock as Evaluated by Calibrated Automated Thrombography. Shock. 43(1). 74–79. 6 indexed citations
10.
Solis, Morgane, et al.. (2013). RBCs inclusions after splenectomy: not only Howell-Jolly bodies!. Annales de biologie clinique. 71(2). 185–189. 5 indexed citations
11.
Perrin, Julien, et al.. (2012). Red blood cell anomalies in the context of hereditary pyropoikilocytosis. Transfusion. 52(8). 1646–1646.
12.
Perrin, Julien, et al.. (2012). A case of hereditary pyropoïkilocytosis with mild expression and delayed onset. Annales de biologie clinique. 70(4). 483–488. 1 indexed citations
13.
Perrin, Julien, Dana Ranta, Fabienne Empereur, et al.. (2011). Polymorphonuclear neutrophils from JAK2V617F positive MPD patients do not support hypercoagulability: A study with calibrated automated thrombography (CAT). Blood Cells Molecules and Diseases. 46(3). 235–238. 3 indexed citations
14.
Richard, Sébastien, et al.. (2010). Cerebral venous thrombosis due to essential thrombocythemia and worsened by heparin-induced thrombocytopenia and thrombosis. Platelets. 22(2). 157–159. 14 indexed citations
16.
Lecompte, Thomas, et al.. (2010). In vitro effects of human neutrophil cathepsin G on thrombin generation: Both acceleration and decreased potential. Thrombosis and Haemostasis. 104(9). 514–522. 6 indexed citations
17.
Richard, Sébastien, Julien Perrin, Pierre-Alexandre Baillot, Jean‐Christophe Lacour, & Xavier Ducrocq. (2010). Ischaemic stroke and essential thrombocythemia: a series of 14 cases. European Journal of Neurology. 18(7). 995–998. 25 indexed citations
18.
Perrin, Julien, M Marchand-Arvier, Véronique Latger‐Cannard, C. Vigneron, & Thomas Lecompte. (2007). [Incubated osmotic fragility test does not exclude red blood cell membrane disorders! About a case of hereditary elliptocytosis].. PubMed. 64(5). 491–5. 1 indexed citations
19.
Perrin, Julien, et al.. (2007). Influence of polymorphonuclear leukocytes on the plasma clot formation as evaluated by thromboelastometry (ROTEM®). Thrombosis Research. 121(5). 647–652. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026